Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma.
Pediatrics. 2018.
PMID: 30478244
Review.
No abstract available.
Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2026 | 0 |
Search Results
10 results
Results by year
Citations
3
articles
found by citation matching
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
Thyroid. 2015.
PMID: 25810047
Free PMC article.
Review.
The 2015 Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the "evidence-based" refusal to endorse them by EANM due to the "not evidence-based" marginalization of the role of Nuclear Medicine.
Eur J Nucl Med Mol Imaging. 2016.
PMID: 27118126
No abstract available.
Search results
Page 1
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
Thyroid. 2015 Jun;25(6):567-610. doi: 10.1089/thy.2014.0335.
Thyroid. 2015.
PMID: 25810047
Free PMC article.
Review.
INTRODUCTION: The American Thyroid Association appointed a Task Force of experts to revise the original Medullary Thyroid Carcinoma: Management Guidelines of the American Thyroid Association. ...R …
INTRODUCTION: The American Thyroid Association appointed a Task Force of experts to revise the original Medul …
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma.
Pediatrics. 2018 Dec;142(6):e20183062. doi: 10.1542/peds.2018-3062.
Pediatrics. 2018.
PMID: 30478244
Review.
No abstract available.
Recent Updates on the Management of Medullary Thyroid Carcinoma.
Endocrinol Metab (Seoul). 2016 Sep;31(3):392-399. doi: 10.3803/EnM.2016.31.3.392. Epub 2016 Aug 26.
Endocrinol Metab (Seoul). 2016.
PMID: 27586449
Free PMC article.
Review.
Medullary thyroid carcinoma (MTC) is a rare neuroendocrine tumor derived from the thyroid C cells producing calcitonin. ...In this review, we summarize the current approach according to revised American Thyroid Association …
Medullary thyroid carcinoma (MTC) is a rare neuroendocrine tumor derived from the thyroid C cells producing calc …
The 2015 Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the "evidence-based" refusal to endorse them by EANM due to the "not evidence-based" marginalization of the role of Nuclear Medicine.
Eur J Nucl Med Mol Imaging. 2016 Jul;43(8):1486-90. doi: 10.1007/s00259-016-3404-7. Epub 2016 Apr 27.
Eur J Nucl Med Mol Imaging. 2016.
PMID: 27118126
No abstract available.
Positron Emission Tomography Imaging in Medullary Thyroid Carcinoma: Time for Reappraisal?
Thyroid. 2021 Feb;31(2):151-155. doi: 10.1089/thy.2020.0674. Epub 2020 Dec 23.
Thyroid. 2021.
PMID: 33191866
Review.
Medullary thyroid carcinomas (MTC) are rare neoplasms derived from calcitonin-secreting cells of the thyroid. ...Over the past 10 years, many consensus or near consensus of expert panels have been published for the treatment and follow-up of MTC (e.g., American …
Medullary thyroid carcinomas (MTC) are rare neoplasms derived from calcitonin-secreting cells of the thyroid. ...Over the past …
Temporal trends in referrals of RET gene carriers for neck surgery to a tertiary surgical center in the era of international management guidelines.
Endocrine. 2023 Apr;80(1):100-110. doi: 10.1007/s12020-022-03273-8. Epub 2022 Dec 2.
Endocrine. 2023.
PMID: 36456885
Free PMC article.
PURPOSE: Thirty years into the genomic era, this study sought to explore events that helped transform the clinical landscape of hereditary medullary thyroid cancer (MTC). METHOD: This retrospective analysis of prospectively collected data included all RET car …
PURPOSE: Thirty years into the genomic era, this study sought to explore events that helped transform the clinical landscape of hereditary …
The role of genetic screening in medullary thyroid cancer: a clinician's view on the recent ATA guidelines.
Expert Rev Endocrinol Metab. 2015 Jul;10(4):345-347. doi: 10.1586/17446651.2015.1057121. Epub 2015 Jun 16.
Expert Rev Endocrinol Metab. 2015.
PMID: 30293499
The American Thyroid Association recently released its revised guidelines on the management of medullary thyroid carcinoma. This editorial highlights the American Thyroid Association recommendatio …
The American Thyroid Association recently released its revised guidelines on the management of …
Clinical comments related to medullary thyroid cancer diagnosis and management.
Thyroid Res. 2013 Mar 14;6 Suppl 1(Suppl 1):S6. doi: 10.1186/1756-6614-6-S1-S6. Epub 2013 Mar 14.
Thyroid Res. 2013.
PMID: 23514614
Free PMC article.
BACKGROUND: The American Thyroid Association (ATA) and more recently the European Thyroid Association (ETA) Guidelines on diagnosis and treatment of medullary thyroid carcinoma (MTC) have provided an excellent tool wh …
BACKGROUND: The American Thyroid Association (ATA) and more recently the European Thyroid Association (ET …
Early diagnosis of medullary thyroid carcinoma: is systematic calcitonin screening appropriate in patients with nodular thyroid disease?
Oncologist. 2011;16(1):49-52. doi: 10.1634/theoncologist.2010-0344. Epub 2011 Jan 6.
Oncologist. 2011.
PMID: 21212427
Free PMC article.
In 2006, the European Thyroid Association (ETA) recommended serum CT measurement in the initial workup of thyroid nodules, whereas the American Thyroid Association (ATA) declined to recommend for or against this approach. In late 2009, th …
In 2006, the European Thyroid Association (ETA) recommended serum CT measurement in the initial workup of thyroid nodul …
Risk Profile of the RET A883F Germline Mutation: An International Collaborative Study.
J Clin Endocrinol Metab. 2017 Jun 1;102(6):2069-2074. doi: 10.1210/jc.2016-3640.
J Clin Endocrinol Metab. 2017.
PMID: 28323957
Free article.
CONTEXT: The A883F germline mutation of the rearranged during transfection (RET) proto-oncogene causes multiple endocrine neoplasia 2B. In the revised American Thyroid Association (ATA) guidelines for the management of medullary …
CONTEXT: The A883F germline mutation of the rearranged during transfection (RET) proto-oncogene causes multiple endocrine neoplasia 2B. In t …
Cite